[1]
Christensen, M.J. Selenium and prostate cancer prevention, What next - if anything? Cancer Prev. Res., 2014, 7(8), 781-785.
[2]
Combs, G.F. Jr. Selenium in global food systems. Br. J. Nutr., 2001, 85(8), 517-547.
[3]
Duntas, L.H.; Benvenga, S. Selenium, an element for life. Endocrine, 2015, 48(3), 756-775.
[4]
Hawkes, W.C.; Alkan, Z. Regulation of redox signaling by selenoproteins. Biol. Trace Elem. Res., 2010, 134, 235-251.
[5]
Nuttall, K.L. Evaluating selenium poisoning. Ann. Clin. Lab. Sci., 2006, 36, 409-420.
[6]
Chen, J. An original discovery, selenium deficiency and Keshan disease (an endemic heart disease). Asia Pac. J. Clin. Nutr., 2012, 21(3), 320-326.
[7]
Rayman, M.P. Food-chain selenium and human health, emphasis on intake. Br. J. Nutr., 2008, 100, 254-268.
[8]
Kieliszek, M.; Blazejczak, S. Selenium, Significance and outlook for supplementation. Nutrition, 2013, 29, 713-718.
[9]
Papp, L.P.; Holmgren, A.; Khanna, K.K. Selenium and selenoproteins in health and disease. Antioxid. Redox Signal., 2010, 12, 793-795.
[10]
Thomson, C.D. Assessment of requirements for selenium and adequacy of selenium status, a review. Eur. J. Clin. Nutr., 2004, 58, 391-402.
[11]
Schrauzer, G.N. Selenium and cancer, A review. Bioinorg. Chem., 1976, 5, 275-281.
[12]
Rayman, M.P. Selenium and human health. Lancet, 2012, 379, 1256-1268.
[13]
Rayman, M.P. Selenium in cancer prevention, a review of the evidence and mechanism of action. Proc. Nutr. Soc., 2005, 64, 527-542.
[14]
Lipinski, B. Is it oxidative or free radical stress and why does it matter? Oxid. Antioxid. Med. Sci., 2012, 1, 5-9.
[16]
Behne, S.S.; Kyriakopoulos, A. Mammalian selenium-containing proteins. Annu. Rev. Nutr., 2001, 21, 453-473.
[17]
Li, F.; Lutz, P.B.; Pepelyaeva, Y.; Arner, E.S.J.; Bayse, C.A.; Rozovsky, S. Redox active motifs in selenoproteins. Proc. Natl. Acad. Sci. USA, 2014, 111, 6976-6981.
[18]
Ip, C. Lessons from basic research in selenium and cancer prevention. J. Nutr., 1998, 128, 1845-1854.
[19]
Vinceti, M.; Maraldi, T.; Bergomi, M.; Malagoli, C. Risk of chronic-low dose selenium overexposure in humans, Insights from epidemiology and biochemistry. Rev. Environ. Health, 2009, 24, 231-248.
[20]
Whanger, P.D. Selenium and its relationship to cancer, an update. Br. J. Nutr., 2004, 91, 11-28.
[21]
Spallholz, J.E. Free radical generation by selenium compounds and their prooxidant toxicity. Biomed. Environ. Sci., 1997, 10, 260-270.
[22]
Wang, Z.; Vincent, J.L.; Forceville, X. A large-bolus injection, but not continuous infusion of sodium selenite improves outcome in peritonitis. Shock, 2010, 33, 555.
[23]
Lipinski, B.; Pretorius, E. Novel pathway of iron-induced blood coagulation, Implications for diabetes mellitus and its complications. Pol. Arch. Med. Wewn., 2012, 122, 116-122.
[24]
Lipinski, B. Hydroxyl radical and its scavengers in health and disease. Oxid. Med. Cell. Longev., 2011, DOI, 10.1155/2011/8099696.
[25]
Lipinski, B.; Pretorius, E. The role of iron-induced fibrin in the pathogenesis of Alzheimer’s disease and the protective role of magnesium. Front. Hum. Neurosci., 2013, 7, 735.
[26]
Lipinski, B. Iron-induced parafibrin formation in tumors fosters immune evasion. OncoImmunology, 2014, 3, e28539, 2014.
[27]
Weekley, C.M.; Harris, H.H. Which form is that? The importance of selenium speciation in the prevention and treatment of disease. Chem. Soc. Rev., 2013, 42, 8870-8894.
[28]
Combs, G.F., Jr Status of selenium in prostate cancer prevention. Br. J. Cancer, 2004, 91(2), 195-199.
[29]
Davis, C.D.; Tsuji, P.A.; Milner, J.A. Selenoproteins and cancer prevention. Annu. Rev. Nutr., 2012, 32, 73-95.
[31]
Jackson, M.I.; Combs, G.F., Jr Selenium and anticarcinogenesis, Underlying mechanisms. Curr. Opin. Clin. Nutr. Metab. Care, 2008, 11(6), 718-726.
[32]
Sanmartin, C.; Plano, D.; Font, M.; Palop, J.A. Selenium and clinical trials, new therapeutic evidence for multiple diseases. Curr. Med. Chem., 2011, 18, 4635-4650.
[33]
Sinha, R.; Medina, S.D. Organic and inorganic selenium compounds inhibit mouse mammary cell growth in vitro by different cellular pathways. Cancer Lett., 1996, 107, 277-284.
[34]
Bao, P.; Chen, Z.; Tai, R.; Shen, H.; Martin, F.L.; Zhu, Y. Selenite-induced toxicity in cancer cells is mediated by metabolic generation of endogenous selenium nanoparticles. J. Proteome Res., 2015, 14(2), 1127-1136.
[35]
Caffrey, P.B.; Frenkel, G.D. Inhibition of cell colony formation by selenite, involvement of glutathione. Mol. Pharmacol., 1991, 39(3), 281-284.
[36]
Chen, J.; Berry, M.J. Selenium and selenoproteins in the brain and brain diseases. J. Neurochem., 2003, 86, 1-12.
[37]
Frenkel, G.D.; Falvey, D.; MacVicar, C. Products of the reaction of selenite with intracellular sulfhydryl groups. Biol. Trace Elem. Res., 1991, 30, 9-18.
[38]
Lothrop, A.P.; Snider, G.W.; Ruggles, E.L.; Patel, A.S.; Lees, W.J.; Hondal, R.J. Selenium as an electron acceptor during the catalytic mechanism of thioredoxin reductase. Biochemistry, 2014, 53, 654-663.
[39]
Husbeck, B.; Peehl, D.M.; Knox, S.J. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing. Free Radic. Biol. Med., 2005, 38, 50-57.
[40]
Park, S.H.; Kim, J.H.; Chi, G.Y.; Kim, G.Y.; Chang, Y.C.; Moon, S.K.; Nam, S.W.; Kim, W.J.; Yoo, Y.H.; Choi, Y.H. Induction of
apoptosis and autophagy by sodium selenite in A549 human lung.
[41]
Kralova, V.; Brigulova, K.; Cervinka, M.; Rudolf, E. Antiproliferative and cytotoxic effects of sodium selenite in human colon cancer. Toxicol. In Vitro, 2009, 23, 1497-1503.
[42]
Kuklinski, B.; Zimmermann, T.; Schweder, R. Decreasing mortality in acute pancreatitis with sodium selenite. Clinical results of 4-year antioxidant therapy. Med. Klin. (Munich), 1995, 90, 36-41.
[43]
de Miranda, J.X.; Andrade, F.O.; de Conti, A.; Daghli, M.L.Z.; Moreno, F.S.; Ong, T.P. Effects of selenium compounds on proliferation and epigenetic marks of breast cancer cells. J. Trace Elem. Med. Biol., 2014, 28(4), 486-491.
[44]
Xu, W.; Ma, W-W.; Zeng, H-H. Synergetic effect of ethaselen and selenite treatment against A549 non-small cell lung cancer cells. Asian Pac. J. Cancer Prev., 2014, 15, 7129-7135.
[45]
Yang, Y.; Huang, F.; Ren, Y.; Xing, L.; Wu, Y.; Li, Z.; Pan, H.; Xu, C. The anticancer effects of sodium selenite and selenomethionine on human colorectal carcinoma cell lines in nude mice. Oncol. Res., 2009, 18(1), 1-8.
[46]
Nelson, M.A.; Porterfield, B.W.; Jacobs, E.T.; Clark, L.C. Selenium and prostate cancer prevention. Semin. Urol. Oncol., 1999, 17, 91-96.
[47]
Platz, E.A.; Helzlsouer, K.J. Selenium, zinc, and prostate cancer. Epidemiol. Rev., 2001, 23, 93-101.
[48]
Kenfield, S.A.; Van Blarigan, E.L.; DuPre, N.; Stampfer, M.J.; Giovannucci, E.; Chan, J.M. Selenium supplementation and prostate
cancer mortality. J. Natl. Cancer Inst, 2014, 107, (1), pii,
dju360.
[49]
Lipinski, B. Rationale for the treatment of cancer with sodium selenite. Med. Hypotheses, 2005, 64, 806-810.
[50]
Lipinski, B. Prostate cancer vaccines, fibrin and selenium, A conceptual review. Open Prostate Cancer J., 2010, 3, 69-73.
[51]
Zhao, R.; Xiang, N.; Domann, F.E.; Zhong, W. Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr. Cancer, 2009, 61, 397-407.
[52]
Freitas, M.; Alves, V.; Sarmento-Ribeiro, A.B.; Mota-Pinto, A. Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line. Biochem. Biophys. Res. Commun., 2011, 408(4), 713-719.
[53]
Cekan, E.; Tribukait, B.; Vocal-Borek, H. Protective effect of selenium against ionizing radiation-induced malformation in mice. Acta Radiol., 1985, 24, 267-271.
[54]
Ghandi, U.H.; Kaushal, N.; Hegde, S.; Finch, E.R.; Kudva, A.K.; Kennett, M.J.; Jordan, C.T.; Paulson, R.F.; Prabhu, K.S. Selenium suppresses leukemia through the action of endogenous eicosanoids. Cancer Res., 2014, 74(14), 3890-3901.
[55]
Wu, S.; Bao, Y.; Ma, D.; Zi, Y.; Yang, C.; Yang, M.; Xing, M.; Yang, W. Sodium selenite inhibits leukemia HL-60 cell proliferation and induces cell apoptosis by enhancing the phosphorylation of JNK1 and increasing the expression of p21 and p27. Int. J. Mol. Med., 2014, 34(4), 1175-1179.
[56]
Yang, Y.; Pan, H.; Xu, C. Requirement for ERK activity in sodium selenite-induced apoptosis of acute promyelocytic leukemia-derived NB4 cells. J. Biochem. Mol. Biol., 2007, 40(2), 196-204.
[57]
Olm, E.; Johnsson-Videsater, K.; Ribera-Cortada, I.; Fernandes, A.P.; Eriksson, L.C.; Lehmann, S.; Rundlof, A.K.; Paul, C.; Bjornstedt, M. Selenite is a potent cytotoxic agent for human primary AML cells. Cancer Lett., 2009, 282, 116-123.
[58]
Pan, H.Z.; Zhang, Z.N. Distinct effects of different concentrations of sodium selenite on apoptosis, cell cycle, and gene expression profile in acute promyeolytic leukemia-derived NB4 cells. Ann. Hematol., 2006, 85, 434-442.
[59]
Jiang, X.R.; Macey, M.G.; Lin, H.X.; Newland, A.C. The anti-leukemic effect and mechanism of sodium selenite. Leuk. Res., 1992, 16, 347-352.
[60]
Zuo, L.; Li, J.; Yang, Y.; Wang, X.; Shen, T.; Xu, C.M.; Zhang, Z.N. Sodium selenite induces apoptosis in acute promyelocytic leukemia-derived NB4 cells by a caspase-3-dependent mechanism and a redox pathway different from that of arsenic trioxide. Ann. Hematol., 2004, 83(12), 751-758.
[61]
Arthur, J.R.; McKenzie, R.C.; Beckett, G.J. Selenium in the immune system. J. Nutr., 2003, 133(5)(Suppl. 1), 1457S-1459S.
[62]
McKenzie, R.C.; Rafferty, T.S.; Beckett, G.J. Selenium, an essential element for immune function. Immunol. Today, 1998, 19, 342-345.
[63]
Turner, R.J.; Finch, J.M. Selenium and the immune response. Proc. Nutr. Soc., 1991, 50, 275-285.
[64]
Taylor, E.W. Selenium and cellular immunity. Biol. Trace Elem. Res., 1995, 49, 85-95.
[65]
Taylor, E.W.; Cox, A.G.; Zhao, L.; Ruzicka, J.A.; Bhat, A.A.; Zhang, W.; Nadimpalli, R.G.; Dean, R.G. Nutrition, HIV, and drug abuse, The molecular basis of a unique role for selenium. JAIDS., 2000, 25, S53-S61.
[66]
Dhur, A.; Galan, P.; Hercberg, S. Relationship between selenium, immunity and resistance against infection. Comp. Biochem. Physiol., 1990, 96C, 271-280.
[67]
Davis, C.D.; Brooks, L.; Calisi, C.; Bennett, B.J.; McElroy, D.M. Beneficial effect of selenium supplementation during murine infection with Trypanosoma cruzi J. Parazitol., 1998, 84, 1274-1277.
[68]
Taguchi, N.; Hatabu, T.; Yamaguchi, H.; Suzuki, M.; Sato, K.; Kano, S. Plasmodium falciparum, selenium-induced cytotoxicity to P. falciparum. Exp. Parasitol., 2004, 106, 50-55.
[69]
Alhazzani, W.; Jacobi, J.; Sindi, A.; Hartog, C.; Reinhart, K.; Kokkoris, S.; Gerlach, H.; Andrews, P.; Drabek, T.; Manzanares, W.; Cook, D.J.; Jaeschke, R.Z. The effect of selenium therapy on mortality in patients with sepsis syndrome, a systematic review and meta-analysis of randomized controlled trials. Crit. Care Med., 2013, 41, 1555-1564.
[70]
Forceville, X. The effect of selenium therapy on mortality in patients with sepsis syndrome, simple selenium supplementation or real (5H2O)·Na2SeO3 pharmacological effect? Crit. Care Med., 2013, 41, 1591-1592.
[71]
Huang, T-S.; Shyu, Y-C.; Chen, H-Y.; Lin, L-M.; Lo, C-Y.; Yuan, S-S.; Chen, P-J. Effect of parenteral selenium supplementation in critically ill patients, a systematic review and meta-analysis. PLoS One, 2013, 8, e54431.
[72]
Manzanares, W.; Langlois, P.L.; Heyland, D.K. Pharmaconutrition with selenium in critically ill patients, what do we know? Nutr. Clin. Pract., 2015, 30(1), 34-43.
[73]
Sakr, Y.; Maia, V.P.; Santos, C.; Stracke, J.; Zeidan, M.; Bayer, O.; Reinhart, K. Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit. Care, 2014, 18, R68.
[74]
Beck, M.A.; Nelson, H.K.; Shi, Q.; van Dael, P.; Schiffrin, E.J.; Blum, S.; Barclay, D.; Levander, O.A. Selenium deficiency increases the pathology of an influenza virus infection. FASEB J., 2001, 15(8), 1481-1483.
[75]
Sighal, N.; Austin, J. A clinical review of micronutrients in HIV infection. J. Int. Assoc. Physic. AIDS Care, 2002, 1, 63-75.
[76]
van Zuuren, E.J.; Albusta, A.Y.; Fedorowicz, Z.; Carter, B.; Pijl, H. Selenium supplementation for Hashimoto’s thyroiditis. Cochrane Database Syst. Rev., 2013, 6, CDO10223.
[77]
Landuci, F.; Mancinelli, P.; De Gaudio, A.R.; Virgili, G. Selenium supplementation in critically ill patients, a systematic review and meta-analysis. J. Crit. Care, 2014, 29(1), 150-156.
[78]
Conner, T.S.; Richardson, A.C.; Miller, J.C. Optimal serum selenium
concentrations are associated with lower depressive symptoms
and negative mood among young adults. J. Nutr, 2014, pii,
jn.114.198010.
[79]
Ramaekers, V.T.; Calomme, M.; Vanden Berghe, D.; Makropoulos, W. Selenium deficiency triggering intractable seizures. Neuropediatrics, 1994, 25, 217-223.
[80]
Sakr, Y.; Maia, V.P.; Santos, C.; Stracke, J.; Zeidan, M.; Bayer, O.; Reinhart, K. Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis. Crit. Care, 2014, 18, R68.
[81]
Imam, S.Z.; Newport, G.D.; Islam, F.; Slikker, W.; Ali, S.F. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergetic neurotoxicity. Brain Res., 1999, 818, 575-578.
[82]
Stranges, S.; Sieri, S.; Vinceti, M.; Grioni, S.; Guallar, E.; Laclaustra, M.; Muti, P.; Berrino, F.; Krogh, V. A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health, 2010, 10, 564.
[83]
Zhou, J.; Huang, K.; Lei, X.G. Selenium and diabetes-evidence from animal studies. Free Radic. Biol. Med., 2013, 65, 1548-1556.
[84]
Allam, M.F.; Lucane, R.A. Selenium supplementation for asthma. Cochrane Database Syst. Rev., 2004, 2, CD003538.
[85]
Gazdik, F.; Pijak, M.R.; Gazdikova, K. Need of complementary therapy with selenium in asthmatics. Nutrition, 2004, 20, 950-952.
[86]
Misso, N.L.; Powers, K.A.; Gillon, R.L.; Stewart, G.A.; Thompson, P.J. Reduced platelet glutathione peroxidase activity and serum selenium concentration in atopic asthmatic patients. Clin. Exp. Allergy, 1996, 26, 838-847.
[87]
Stone, J.; Hinks, L.J.; Beasley, R.; Holgate, S.T.; Clayton, B.A. Reduced selenium status of patients with asthma. Clin. Sci., 1989, 77, 495-500.
[88]
Hasselmark, L.; Malmgren, R.; Zetterstrom, O.; Unge, G. Selenium supplementation in intrinsic asthma. Allergy, 1993, 48, 30-36.
51
2
